IRMD - IRadimed Corporation

NasdaqCM - NasdaqCM Real Time Price. Currency in USD
Currency in USD

Valuation Measures

Market Cap (intraday) 5
262.77M
Enterprise Value 3
219.89M
Trailing P/E
34.67
Forward P/E 1
24.87
PEG Ratio (5 yr expected) 1
1.70
Price/Sales (ttm)
7.31
Price/Book (mrq)
5.05
Enterprise Value/Revenue 3
6.11
Enterprise Value/EBITDA 6
23.33

Trading Information

Stock Price History

Beta (3Y Monthly) 1.56
52-Week Change 3-14.53%
S&P500 52-Week Change 318.19%
52 Week High 329.80
52 Week Low 316.68
50-Day Moving Average 323.35
200-Day Moving Average 321.35

Share Statistics

Avg Vol (3 month) 365.66k
Avg Vol (10 day) 348.06k
Shares Outstanding 511.48M
Float 5.54M
% Held by Insiders 154.87%
% Held by Institutions 123.43%
Shares Short (Nov 15, 2019) 4446.95k
Short Ratio (Nov 15, 2019) 46.56
Short % of Float (Nov 15, 2019) 48.68%
Short % of Shares Outstanding (Nov 15, 2019) 43.89%
Shares Short (prior month Oct 15, 2019) 4408.94k

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 3N/A
Trailing Annual Dividend Yield 3N/A
5 Year Average Dividend Yield 4N/A
Payout Ratio 40.00%
Dividend Date 3N/A
Ex-Dividend Date 4N/A
Last Split Factor (new per old) 2N/A
Last Split Date 3N/A

Financial Highlights

Fiscal Year

Fiscal Year Ends Dec 31, 2018
Most Recent Quarter (mrq)Sep 30, 2019

Profitability

Profit Margin 22.51%
Operating Margin (ttm)22.80%

Management Effectiveness

Return on Assets (ttm)9.37%
Return on Equity (ttm)17.63%

Income Statement

Revenue (ttm)35.97M
Revenue Per Share (ttm)3.23
Quarterly Revenue Growth (yoy)30.80%
Gross Profit (ttm)23.23M
EBITDA 9.42M
Net Income Avi to Common (ttm)8.1M
Diluted EPS (ttm)0.66
Quarterly Earnings Growth (yoy)2.30%

Balance Sheet

Total Cash (mrq)42.56M
Total Cash Per Share (mrq)3.71
Total Debt (mrq)3.01M
Total Debt/Equity (mrq)5.82
Current Ratio (mrq)9.82
Book Value Per Share (mrq)4.53

Cash Flow Statement

Operating Cash Flow (ttm)9.83M
Levered Free Cash Flow (ttm)6.86M